China NMPA Product Recall - Knee components

Biomet Orthopedics initiated a voluntary Level II recall of specific batches of its Vanguard PS open-box femoral condyle prostheses. This recall was reported to China's National Medical Products Administration (NMPA) by Bangmei (Shanghai) Trading Co., Ltd. on January 7, 2017, and subsequently published by the NMPA on February 21, 2017. The core issue was incorrect product packaging labeling, where some femoral condyle prostheses were potentially mislabeled with an incorrect size (smaller or larger) or the wrong side (right/left). This manufacturing deviation stemmed from inadequate supplier clearance procedures identified between April 5, 2016, and September 1, 2016. The global recall affected 3301 units, with 2322 units distributed in China. Despite a low estimated incidence rate of 0.001% and no reported adverse events or complaints in China, Biomet Orthopedics proactively implemented the recall. All unused affected products have been successfully retrieved and returned to the manufacturer, ensuring adherence to regulatory standards and patient safety.